The suspension of PEPFAR funding will have a significant impact on South Africa which has 5.9 million people on antiretroviral therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback